Cryoport and Ocasa Align for Global Cold Chain

September 26, 2013

LAKE FOREST, CA – September 26, 2013 — Cryoport, Inc. (OTCBB: CYRX) and OCASA, Inc. have entered into a master services agreement to provide global cold chain logistics solutions for life science and biotech commodities requiring cryogenic temperatures. OCASA will have access to Cryoport’s full range of cryogenic business solution capabilities including its proprietary Cryoport Express® Shippers and cloud-based logistics management software platform, the CryoportalTM. Cryoport will leverage OCASA’s global logistics network to provide more complete global services to its customers. In conjunction with Cryoport and OCASA providing each other with logistics solutions, the Companies will engage in co-marketing, joint sales activities, and a wide range of customer-driven support requirements to provide comprehensive and seamless solutions to the life sciences and biotech industries.

Read More

Tags: Dry Shipper, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Zoetis, Pfizer, frozen shipping solution, Vaccines, Animal HealthDry Shipper, OCASA